Drugs / BC106 insulin lispro
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02528396 | Aug → Dec 2015 | type 1 diabetes mellitus | Adocia | Completed | No outcome recorded |
| Phase 1 | NCT01638325 | Jul → Sep 2012 | — | Adocia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BC106 insulin lispro | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01638325 ↗ |
| Known as | BioChaperone insulin lispro | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02528396 ↗ |
| Route | Subcutaneous | “Administered SC” NCT01638325 ↗ |